Search:
|
|
|
 |
|
 |
| |
| May 4, 2009 (Monday) |
| 10:30 a.m. |
| Axonal Degeneration (Multiple Sclerosis) |
| Overview |
| MS and demyelinating disease |
| Dennis Bourdette |
| This session will overview the clinical spectrum of demyelinating disease
(principally MS in this discussion) and highlight some of the key issues in the neurobiology
and approaches to treatment. |
- What are the essential components of making a clinical diagnosis of MS?
- What aspects of MS are most affected by beta interferon and copolymer-1?
- What current treatments address myelin repair or neurodegeneration in MS?
|
| |
- Weiner HL (2009). The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
Ann Neurol 65:239-248.
- Quarles RH, Morell P, McFarland HF (2006). Diseases involving myelin.
In Basic Neurochemistry, 7th Ed., (GJ Siegel, RW Albers, ST Brady, DL Price, eds.),
Elsevier Academic Press, 639-652
|
- http://media.ohsu.edu/ramgen/sch/ogi/neus/626-050409.rm
|
|
|
 |
|
 |
|